| #451 |
Todd Mead |
— |
1 |
| #451 |
Mike Humphrey |
— |
1 |
| #451 |
Phil Nuytten |
— |
1 |
| #451 |
Lauren Walker |
Creo Products Limited |
1 |
| #451 |
Harvey O. Coxson |
University Of British Columbia |
1 |
| #451 |
Alexandre Rojkov |
Sap Se |
1 |
| #451 |
Ronald Vijay Dharam Raey |
— |
1 |
| #451 |
Aaron M. Isabel |
— |
1 |
| #451 |
David Brian O'Neill |
Electronic Arts |
1 |
| #451 |
Mehdi Mirzaaghaei |
Amazon |
1 |
| #451 |
Reno Gajo |
— |
1 |
| #451 |
Nathalie Rauschmayr |
Amazon |
1 |
| #451 |
Kyle D. Sauve |
Westport Power |
1 |
| #451 |
Nima Ahrari |
— |
1 |
| #451 |
Mehdi Ahrari |
— |
1 |
| #451 |
David L. Trueman |
— |
1 |
| #451 |
Jennifer S. Nyland |
Tanisys Technology |
1 |
| #451 |
J. L. Martin Lord |
Mpr Teltech |
1 |
| #451 |
Hayes Wong |
— |
1 |
| #451 |
Bill McWilliam |
— |
1 |
| #451 |
Sarah Melinda Duncan |
— |
1 |
| #451 |
Afshin Doustmohammadi |
Advanced Intelligent Systems |
1 |
| #451 |
Brian Wilson |
— |
1 |
| #451 |
Penelope Reiner |
— |
1 |
| #451 |
Ernest Janzen |
— |
1 |
| #451 |
Dave O'Neill |
Redback Networks |
1 |
| #451 |
Jacob H. Heilbron |
— |
1 |
| #451 |
Errol Clyde Klotz |
— |
1 |
| #451 |
Steven M. Rae |
Motorola |
1 |
| #451 |
Bruce Davis |
— |
1 |
| #451 |
Milivoj Plisic |
— |
1 |
| #451 |
Donald James Froese |
General Fusion |
1 |
| #451 |
Maneet Maghera |
Novarc Technologies |
1 |
| #451 |
Matthew Pryl |
Verathon |
1 |
| #451 |
Emile Earl Godin |
— |
1 |
| #451 |
Brian Follett |
— |
1 |
| #451 |
Steve Wrinch |
Darkvision Technologies |
1 |
| #451 |
Brent G. Olund |
— |
1 |
| #451 |
Ryan Brough |
Mastercard |
1 |
| #451 |
Matthias Einwag |
Amazon |
1 |
| #451 |
Miles Fenton |
— |
1 |
| #451 |
Jens Niegemann |
Ansys |
1 |
| #451 |
Ives José de Albuquerque Macêdo, Jr. |
Ada Support |
1 |
| #451 |
Cecil Lau |
Mastercard |
1 |
| #451 |
Armin Khatoonabadi |
— |
1 |
| #451 |
Eric Van Der Eerden |
— |
1 |
| #451 |
Alex Ferrier |
— |
1 |
| #451 |
Hamid Attarzadeh |
— |
1 |
| #451 |
Anna Malgorzata Celler |
University Of British Columbia |
1 |
| #451 |
Ian C. Mortimer |
Protiva Biotherapeutics |
1 |